AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …

Aims To determine whether the Global Anticoagulant Registry in the FIELD–Atrial Fibrillation
(GARFIELD-AF) integrated risk tool predicts mortality, non-haemorrhagic stroke/systemic …

Optimal stroke prevention using oral anticoagulant (OAC) therapy is essential for the
management of patients with atrial fibrillation (AF) who are at increased risk of stroke, but …

Background Balancing the risks of recurrent ischaemic stroke and intracranial haemorrhage
is important for patients treated with antithrombotic therapy after ischaemic stroke or …

Atrial fibrillation (AF) is the most common arrhythmia in adults worldwide and represents an
important burden for patients, physicians, and healthcare systems. AF is associated with …

Stroke risk may be more than 3-fold higher among patients with chronic kidney disease
stage 5D (CKD-5D) compared to the general population, with the highest stroke rates noted …

Background Heart failure (HF) patients have high risks of thromboembolic events regardless
of the category of left ventricular ejection fraction. We sought to assess whether the …

Background: The HAS-BLED, HEMORR 2 HAGES, ATRIA, and ORBIT scores are used to
predict bleeding risk in anticoagulated patients with atrial fibrillation (AF). Recently, these …